|
| |
UGD381
|
|
|
Recommended
applications: RNA or
protein general tissue profiling using IHC or ISH for the urinary/
genital system; Antibody characterization.
Description: 38 cases of normal, inflammatory and neoplastic
conditions from the urinary/genital system. All the tissues were from
surgical resection. They were fixed in 10% neutral buffered formalin for
24 hours and processed using identical SOPs. Sections were picked onto
Superfrost Plus or APES coated Superfrost slides. They all have a
guaranteed six months' shelf-life at 4C from the date of shipment. Each
slide has >95% tissue core retention. |
| |
|
|
|
|
|
| |
|
|
Array
position |
Sex(es) |
Age(s) |
Pathology |
Anatomic site |
Image |
| A1 |
F |
37 |
Renal
cortex |
Kidney |
|
|
A2 |
F |
37 |
Renal medullary |
Kidney |
|
| A3 |
F |
44 |
Chronic pyelonephritis |
Kidney |
|
| A4 |
M |
36 |
Renal
atrophy |
Kidney |
|
| A5 |
F |
52 |
Renal
tuberculosis |
Kidney |
|
| A6 |
M |
41 |
Clear
cell carcinoma |
Kidney |
|
| A7 |
M |
55 |
Clear
cell carcinoma |
Kidney |
|
| A8 |
M |
74 |
Papillary carcinoma |
Kidney |
|
| B1 |
M |
53 |
Normal bladder |
Bladder |
|
| B2 |
F |
64 |
Transitional cell cacinoma |
Bladder |
|
| B3 |
M |
51 |
Transitional cell cacinoma |
Bladder |
|
| B4 |
M |
49 |
Normal prostate |
Prostate |
|
| B5 |
M |
65 |
Hyperplasia |
Prostate |
|
| B6 |
M |
61 |
Hyperplasia |
Prostate |
|
| B7 |
M |
49 |
Adenocarcinoma |
Prostate |
|
| B8 |
M |
63 |
Adenocarcinoma |
Prostate |
|
| C1 |
M |
47 |
Squamous cell carcinoma |
Penis |
|
| C2 |
M |
48 |
Normal testis |
Testis |
|
| C3 |
M |
55 |
Seminoma |
Testis |
|
| C4 |
M |
29 |
Seminoma |
Testis |
|
| C5 |
F |
38 |
Normal ovary |
Ovary |
|
| C6 |
F |
44 |
Adenocarcinoma |
Ovary |
|
|
C7 |
F |
63 |
Adenocarcinoma |
Ovary |
|
|
C8 |
F |
47 |
Adenocarcinoma |
Ovary |
|
|
D1 |
F |
41 |
Teratoma |
Ovary |
|
|
D2 |
F |
33 |
Normal cervix |
Cervix |
|
|
D3 |
F |
28 |
Polyps |
Cervix |
|
|
D4 |
F |
31 |
Squamous cell carcinoma, grade I |
Cervix |
|
|
D5 |
F |
47 |
Squamous cell carcinoma, grade II |
Cervix |
|
|
D6 |
F |
62 |
Squamous cell carcinoma, grade III |
Cervix |
|
|
D7 |
F |
59 |
Normal endometrium |
Endometrium |
|
|
D8 |
F |
41 |
Adenocarcinoma, grade I |
Endometrium |
|
|
E1 |
F |
39 |
Adenocarcinoma, grade II |
Endometrium |
|
|
E2 |
F |
72 |
Adenocarcinoma, grade III |
Endometrium |
|
|
E3 |
F |
33 |
Normal myometrium |
Myometrium |
|
|
E4 |
F |
31 |
Leiomyoma |
Myometrium |
|
|
E5 |
F |
52 |
Leiomyosarcoma |
Myometrium |
|
|
E6 |
F |
43 |
Squamous cell carcinoma |
Vulva |
|
|
|
+32 (0) 16
58 90 45 
+32 (0) 16
50 90 45
